Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132204) titled 'A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of MI078 capsules in the treatment of postpartum depression patients' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing An Ding Hospital, Capital Medical University
Condition:
Postpartum depression
Intervention:
Placebo group:MI078 Capsule Simulator
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2026-09-10
Target Sample Size: Placebo group:100;Experimental group:100;
Countries of Recruitment:
China
To know more, visit h...